GlassScriptPhysician profile
Sandy B Nosseir
NPI 1043464704
$10,519.64
in general payments reported to CMS, 2019-2025
20 companies · $3,073 in 2025
The $3,073 reported for 2025 was more than what 78% of Urogynecology and Reconstructive Pelvic Surgery (Urology) providers received nationally (typical 2025 total: $782).
See the full distribution for Urogynecology and Reconstructive Pelvic Surgery (Urology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $52.39 · 2021: $66.96 · 2022: $27.87 · 2023: $409 · 2024: $6,704 · 2025: $3,073.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,000 · Education: $1,770 · Food and Beverage: $1,416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,000.00 |
| Education | $1,769.97 |
| Food and Beverage | $1,415.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Femselect INC. | $7,500.88 | 2024-2025 | Enplace |
| Intuitive Surgical, INC. | $1,629.77 | 2024 | |
| Astellas Pharma US INC | $376.46 | 2019-2024 | Veozah |
| Sumitomo Pharma America, INC. | $253.82 | 2023-2025 | Gemtesa, Myfembree |
| Coloplast Corp | $172.02 | 2019-2024 | |
| Boston Scientific Corporation | $122.00 | 2025 | Solyx Sis System, Axonics, Bulkamid |
| Axonics, INC. | $106.72 | 2021-2024 | Axonics |
| Baxter Healthcare | $70.87 | 2025 | Perclot |
| Bluewind Medical | $51.23 | 2024 | Revi |
| Pfizer INC. | $38.15 | 2019-2020 | |
| Coopersurgical, INC. | $36.66 | 2023-2025 | Sos, Summit Doppler |
| Urovant Sciences INC | $27.87 | 2022 | |
| Allergan, INC. | $22.99 | 2019 | |
| Teleflex LLC | $19.84 | 2025 | Quikclot |
| Sage Therapeutics, LLC | $18.59 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $17.19 | 2025 | |
| Medtronic, INC. | $16.93 | 2024 | Interstim |
| Myovant Sciences INC. | $15.61 | 2021 | |
| Ambu INC. | $13.56 | 2025 | |
| Meditrina | $8.48 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandy Nosseir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.